Pantai Hospital Kuala Lumpur Advances Adult Congenital Heart Care with First Minimally Invasive PDA Device Closure

KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a patent ductus arteriosus (PDA) in an adult patient with congenital heart disease — a first for the hospital's Interventional Cardiology Laboratory (ICL).

The patient, who was initially referred for open-heart surgery involving PDA ligation and ventricular septal defect (VSD) closure, was carefully evaluated by PHKL's multidisciplinary cardiac team. A detailed transoesophageal echocardiogram (TOE) revealed a single tiny VSD that did not require immediate surgical repair, allowing the team to opt for a less invasive, catheter-based approach.

"This case is a testament to multidisciplinary, patient-centred approach," said Dr Siti Laura, Consultant Paediatric Cardiothoracic Surgeon at PHKL. "By opting for a minimally invasive PDA device occlusion, we were able to offer the patient a faster recovery, smaller incision, and significantly reduced scarring."

This successful procedure highlights PHKL's expanding capabilities in adult congenital heart care, a specialised and growing field that requires collaborative planning and tailored interventions. It also reflects the hospital's commitment to delivering innovative, minimally invasive solutions for structural heart conditions in adults — a group often underrepresented in congenital cardiac care

Our ability to perform such procedures reflects the hospital's continuous investment in advanced cardiac technology and our commitment to improving outcomes for patients with congenital heart disease," Dr Siti Laura added. "We will continue to monitor the patient's condition closely — particularly her VSD — to ensure optimal long-term care.

PHKL reinforces its position as a tertiary referral centre and a growing centre of excellence for adult congenital heart disease management in Malaysia. For more information about Paediatric and Congenital Cardiothoracic Services at PHKL, please visit: https://www.pantai.com.my/kuala-lumpur/congenital-cardiothoracic.

-END-

***

Dr Siti Laura Mazalan,
Consultant Paediatric and Congenital Cardiothoracic Surgeon

MBBS (University of Malaya, Malaysia), MMed Surg (University Kebangsaan Malaysia, Malaysia), Fellowship in Paediatric Cardiac Surgery (Birmingham Children Hospital, United Kingdom)

Dr. Siti Laura is a highly accomplished Paediatric Cardiothoracic Surgeon deeply committed to serving vulnerable in Malaysia. Her medical journey commenced with an MBBS from the University of Malaya in 1998, followed by a Master of Medicine (Surgery) from Universiti Kebangsaan Malaysia in 2004. Beginning her career at Institute Jantung Negara in 2004, she devoted 14 years to the institution as a Consultant Cardiothoracic Surgeon. Motivated by her dedication to enhancing healthcare, she pursued a transformative one-year Fellowship in Paediatric Cardiac Surgery at Birmingham Children's Hospital in 2010.

In 2020, Dr. Siti Laura joined Serdang Hospital, where she played a pivotal role in establishing the Paediatric Cardiothoracic service, catering to underprivileged children with congenital heart diseases in the nation. She subsequently became a Consultant Paediatric Cardiothoracic Surgeon at Pantai Hospital Kuala Lumpur. Dr Siti Laura's area of interest includes Neonatal and Paediatric Cardiothoracic Surgery, Adult Congenital Cardiac Surgery, Single Ventricle Heart Surgery, ECMO support (Extracorporeal membrane oxygenation), Slide Tracheoplasty Surgery in neonates and paediatric patients and Cardiac Homograft Banking. Dr Siti Laura's expertise and unwavering dedication continue to make a profound impact on the lives of her patients and the healthcare community.

***

About Pantai Hospital Kuala Lumpur

For five decades, Pantai Hospital Kuala Lumpur has been the heartbeat of Kuala Lumpur, steadfastly delivering exceptional care to patients from all walks of life. Since its inception in 1974 with just 68 beds and 20 medical specialists, the hospital has grown into a healthcare icon today with 507 beds, over 200 consultants and counting. Our pursuit of quality healthcare, clinical excellence, and cutting-edge technology is underscored by our service quality and dedication towards clinical research.

This has earned us accreditations from the Malaysian Society for Quality in Health (MSQH) and the Joint Commission International (JCI). Additionally, we hold certification as a Baby-Friendly Hospital and is a preferred hospital in Malaysia by the World Health Organization (WHO). As we celebrate our 50th anniversary, Pantai Hospital Kuala Lumpur looks to the future, unwaveringly committed to continuing its legacy of excellence with world-class healthcare services and innovative treatments for generations to come. Learn more at www.pantai.com.my/kuala-lumpur.

For more information, please contact:
Callie Phin, Pantai Hospital Kuala Lumpur
Email: callie.phin@pantai.com.my
Tel No.: 014-686 7066

For media enquiry:
Natasha Loo, PR Lab Consultancy
Email: tasha@pr-lab.co
Tel No.: 010-231 0110

Lim Joe Ee, PR Lab Consultancy
Email: joe.lim@pr-lab.co
Tel No.: 012-635 9839

Ally Chai, PR Lab Consultancy
Email: ally@pr-lab.co
Tel No.: 016-232 7625

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/pantai-hospital-kuala-lumpur-advances-adult-congenital-heart-care-with-first-minimally-invasive-pda-device-closure-302474408.html

SOURCE Pantai Hospital Kuala Lumpur